coronaviru
respons
sever
acut
respiratori
syndrom
sarscov
contain
small
envelop
protein
e
put
involv
host
cell
apoptosi
viru
morphogenesi
suggest
e
protein
form
membran
destabil
transmembran
tm
hairpin
homooligomer
form
regular
tm
ahel
bundl
shown
previous
topolog
ahel
put
tm
domain
e
protein
etm
flank
two
lysin
residu
c
n
termini
improv
solubl
consist
regular
tm
ahelix
orient
paramet
lipid
bilay
consist
homopentamer
model
herein
show
peptid
reconstitut
lipid
bilay
show
sodium
conduct
channel
activ
inhibit
antiinfluenza
drug
amantadin
found
bind
prepar
moder
affin
result
obtain
singl
doubl
mutant
indic
organ
transmembran
pore
consist
previous
report
pentamer
ahel
bundl
model
caus
agent
sever
acut
respiratori
syndrom
sar
sarscov
member
famili
coronavirida
rota
et
al
caus
common
cold
human
respons
seriou
diseas
anim
speci
lipid
bilay
surround
virion
typic
emb
three
protein
spike
membran
envelop
e
protein
protein
studi
import
role
receptor
bind
virion
bud
e
protein
sarscov
viru
small
acid
integr
membran
protein
one
put
transmembran
ahel
tmh
hydrophob
domain
amino
acid
long
flank
short
ntermin
region
amino
acid
longer
ctermin
tail
hydrophil
protein
found
critic
viral
bud
mous
hepat
viru
mhv
fischer
et
al
also
mani
coronavirus
coexpress
e
protein
probabl
interact
via
cytoplasm
domain
pregolgi
compart
lim
liu
necessari
morphogenesi
bo
et
al
cors
macham
function
role
suggest
e
protein
promot
apoptosi
et
al
chen
et
al
alter
membran
permeabl
express
escherichia
coli
mammalian
cell
liao
et
al
somewhat
relat
phenomenon
cationselect
ion
channel
activ
wilson
et
al
observ
vitro
report
synthet
fulllength
sarscov
e
protein
also
ntermin
residu
fragment
encompass
ahel
transmembran
domain
wilson
et
al
channel
activ
e
protein
two
coronavirus
shown
block
hexamethylen
amilorid
wilson
et
al
effect
correl
inhibit
replic
virus
point
possibl
pharmacolog
target
coronaviru
infect
although
precis
function
put
channel
well
known
result
suggest
e
protein
coronavirus
specif
sarscov
belong
viroporin
class
protein
pinto
et
al
ewart
et
al
van
kuppeveld
et
al
bodelon
et
al
fischer
sansom
gonzalez
carrasco
one
member
class
influenza
viru
bind
drug
amantadin
high
affin
hay
et
al
amantadin
long
use
treatment
influenza
fleme
drug
also
use
abolish
ion
conduct
hepat
c
viru
protein
hcv
also
suggest
viroporin
griffin
et
al
inde
amantadin
combin
drug
shown
degre
success
hcv
clinic
trial
torr
et
al
zilli
et
al
analog
amantadin
treatment
may
benefici
sarscov
infect
channel
properti
suggest
sarscov
e
protein
may
caus
oligomer
transmembran
domain
etm
form
ahel
bundl
inde
shown
recent
synthet
transmembran
domain
sarscov
e
flank
two
lysin
residu
k
etmk
improv
solubl
insert
lipid
bilay
regular
ahelix
torr
et
al
multipl
infrar
dichroic
data
consist
one
homopentamer
model
obtain
comput
use
evolutionari
conserv
data
torr
et
al
propos
ahel
bundl
respons
channel
activ
observ
predict
howev
contrast
short
ahel
hairpin
topolog
suggest
use
slightli
longer
etm
contain
flank
lysin
residu
arb
et
al
khattari
et
al
herein
perform
experi
determin
peptid
k
etmk
sever
mutant
show
channel
properti
consist
observ
fulllength
ntermin
peptid
sarscov
e
wilson
et
al
also
want
test
amantadin
block
channel
activ
measur
bind
affin
result
suggest
modifi
peptid
k
etmk
explain
channel
properti
etm
use
model
studi
channel
form
sarscov
e
peptid
synthes
k
etmk
mutant
shown
figur
posit
mutat
residu
context
ahel
pentamer
bundl
model
report
previous
torr
et
al
shown
figur
latter
figur
show
residu
face
lumen
pore
wherea
orient
toward
lipid
environ
sd
electrophores
peptid
shown
figur
shown
show
similar
pattern
mobil
consist
dimer
trimer
pentam
signific
amount
monom
kda
detect
even
case
doubl
mutat
latter
case
like
nativ
monomermonom
interact
affect
therefor
band
found
like
repres
nonn
interact
induc
sd
result
ident
publish
wildtyp
label
wt
fig
torr
et
al
torr
et
al
figur
show
conduct
result
peptid
k
etmk
mutant
iv
plot
correspond
experi
use
estim
conduct
shown
figur
wildtyp
wt
fig
conduct
ps
consist
observ
previou
report
fulllength
ntermin
fragment
wilson
et
al
demonstr
stretch
amino
acid
use
respons
channel
activ
also
point
conduct
observ
presenc
two
lysin
residu
n
c
termini
introduc
increas
solubl
facilit
purif
synthet
peptid
singlemut
show
conduct
voltag
test
see
fig
consist
orient
residu
toward
center
pore
see
fig
torr
et
al
singlemut
show
conduct
ps
consist
orient
residu
toward
lipid
environ
see
fig
doublemut
show
conduct
ps
ps
respect
figur
synthet
peptid
correspond
transmembran
ahel
domain
sarscov
e
etm
protein
residu
sever
mutant
flank
two
lysin
residu
c
n
termini
mutat
introduc
indic
bold
number
top
correspond
sarscov
e
protein
sequenc
despit
fact
contain
mutat
latter
mutat
shown
complet
abolish
conduct
high
conduct
observ
mutant
could
due
nonspecif
destabil
membran
test
hypothesi
compar
ion
select
wt
doublemut
fig
figur
panel
c
show
asymmetr
currentvoltag
relationship
wildtyp
sequenc
wt
indic
permeabl
sodium
ion
calcium
ion
contrast
doubl
mutant
show
symmetr
currentvoltag
relationship
indic
cation
specif
effect
addit
amantadin
conduct
shown
figur
amantadin
block
conduct
nativ
sequenc
wt
mutant
suggest
nativ
close
nativ
organ
monom
two
sampl
howev
conduct
doubl
mutant
affect
addit
amantadin
may
reflect
signific
structur
chang
two
situat
possibl
amantadin
still
bind
effect
inhibit
ion
flow
amantadin
bind
latter
state
would
explain
high
conduct
doubl
mutant
rel
singl
mutant
destabil
membran
determin
affin
amantadin
pore
form
etm
mutant
lipid
bilay
use
surfac
plasmon
reson
spr
figur
depict
amantadin
doserespons
curv
obtain
equilibrium
condit
sequenc
shown
figur
data
fit
use
model
assum
onetoon
bind
amantadin
channel
figur
show
amantadin
bind
rel
high
affin
nativ
etm
affin
compar
observ
influenza
depend
strain
astrahan
et
al
predict
model
figur
signific
bind
observ
k
mm
wherea
appear
nonspecif
aggreg
observ
suggest
alter
nativ
oligomer
structur
sampl
also
consist
observ
conduct
inhibit
amantadin
fig
despit
fact
sampl
show
high
conduct
therefor
conclud
latter
due
membran
permeabil
case
observ
mutat
disrupt
ion
channel
conduct
amantadin
bind
expect
attend
conserv
polar
residu
q
n
posit
torr
et
al
coronaviru
envelop
protein
howev
result
obtain
mutat
could
anticip
absenc
model
summari
result
confirm
ion
conduct
properti
sarscov
e
resid
transmembran
domain
also
show
peptid
flank
two
lysin
residu
k
etmk
torr
et
al
homopentamer
ahel
bundl
model
propos
good
figur
slice
etm
pentamer
ahel
bundl
torr
et
al
torr
et
al
residu
mutat
work
indic
insid
circl
model
studi
channel
properti
report
peptid
incorpor
lipid
bilay
bind
amantadin
rel
high
affin
least
compar
influenza
result
may
therapeut
implic
treatment
sar
infect
peptid
correspond
transmembran
domain
sarscov
e
residu
two
lysin
residu
flank
n
c
termini
obtain
describ
previous
torr
et
al
wm
keck
biotechnolog
resourc
center
peptid
cleav
resin
trifluoroacet
acid
tfa
lyophil
lyophil
peptid
dissolv
trifluoroethanol
tfe
tfa
acetonitril
vvv
final
peptid
concentr
ca
mgml
inject
jupit
column
phenomenex
equilibr
h
peptid
elut
achiev
linear
gradient
final
solvent
composit
h
acetonitril
use
water
hplc
system
solvent
contain
vv
tfa
result
fraction
pool
lyophil
peptid
puriti
confirm
electrospray
mass
spectrometri
esi
sampl
delet
truncat
puriti
approxim
mg
lyophil
peptid
mg
avanti
polar
lipid
dissolv
ml
hfip
solut
mix
h
hfip
complet
evapor
proteinlipid
mixtur
dissolv
filter
degass
phosphatebuff
salin
pb
ph
mm
na
hpo
nah
po
mm
nacl
mm
kcl
final
lipid
concentr
mm
solut
mix
min
result
suspens
peptid
reconstitut
liposom
proper
etm
reconstitut
lipid
bilay
confirm
fourier
transform
infrar
ftir
spectroscopi
torr
et
al
amid
band
center
cm
shown
consist
ahelix
liposom
resiz
uniform
diamet
nm
extrus
avanti
mini
extrud
nm
polycarbon
membran
bind
measur
perform
biacor
system
chip
substrat
allow
liposom
bind
cooper
et
al
chip
clean
prior
experi
mm
triton
ml
flow
rate
mlmin
liposom
immobil
one
flow
cell
chip
ml
flow
rate
mlmin
excess
unbound
liposom
remov
mm
naoh
pb
ml
flow
rate
mlmin
follow
pb
flow
h
rate
mlmin
amantadin
inject
ml
flow
rate
mlmin
concentr
rang
mm
membran
immobil
chip
end
inject
equilibrium
amantadin
allow
dissoci
min
pb
subsequ
surfac
regener
pb
mlmin
flow
rate
min
experi
includ
immobil
empti
liposom
ie
without
peptid
one
flow
cell
use
refer
mean
ru
reson
unit
last
sec
amantadin
inject
empti
liposom
cell
subtract
mean
ru
time
period
cell
contain
reconstitut
etm
due
fact
onand
offrat
constant
amantadin
bind
etm
rapid
thermodynam
analys
base
equilibrium
steadyst
measur
see
bind
result
repres
doserespons
curv
final
rueq
plot
amantadin
concentr
doserespons
curv
fit
accord
equat
associ
constant
given
concentr
amantadin
inject
ru
max
ru
etm
channel
satur
amantadin
ru
eq
ru
equilibrium
given
concentr
amantadin
astrahan
et
al
k
k
obtain
k
k
dissoci
constant
k
deriv
use
biaevalu
program
biacor
good
fit
estim
x
valu
good
fit
estim
x
valu
well
case
etm
calcul
ru
max
normal
multipl
constant
factor
astrahan
et
al
fit
curv
program
run
produc
calibr
x
compar
differ
etm
x
model
use
analyz
surfac
plasmon
reson
spr
data
assum
bind
stoichiometri
amantadin
etm
astrahan
et
al
synthet
pope
pop
popc
dimyristoylphosphotidylcholin
dmpc
purchas
avanti
polar
lipid
decan
n
obtain
sigmaaldrich
chloroform
sigmaaldrich
ethanol
sodium
chlorid
nacl
obtain
fluka
ion
channel
format
etm
measur
wilson
et
al
form
planar
lipid
bilay
across
apertur
wall
delrin
cup
separ
aqueou
solut
ci
tran
chamber
work
volum
ml
chamber
lipid
mixtur
pope
pop
popc
mgml
dissolv
chloroform
dri
n
ga
lipid
figur
effect
amantadin
addit
mm
see
arrow
conduct
peptid
shown
figur
except
show
conduct
fig
cake
resuspend
decan
small
amount
lipid
mixtur
paint
across
apertur
delrin
cup
mg
sarscov
etm
protein
ad
ci
chamber
continu
stir
ion
channel
activ
detect
typic
min
chamber
contain
mm
nacl
mm
hepe
ph
ci
mm
nacl
mm
hepe
ph
tran
record
perform
asymmetr
ionic
condit
use
differ
buffer
ci
tran
solut
connect
via
agagcl
electrod
nacl
agar
bridg
current
amplifi
use
warner
instrument
amplifi
digit
khz
filter
khz
use
pclamp
softwar
axon
instrument
inc
tran
chamber
set
refer
ci
chamber
held
differ
potenti
rang
mv
mv
increment
stir
stop
detect
channel
activ
ion
select
experi
perform
mm
nacl
mm
hepe
ph
ci
chamber
mm
cacl
mm
hepe
ph
tran
chamber
